Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells.
Weijie GaoYuliang WangShan YuZhu WangTaiyang MaAndrew Man-Lok ChanPeter Ka-Fung ChiuChi-Fai NgDinglan WuFranky Leung ChanPublished in: Stem cell research & therapy (2022)
Enhanced eNOS-NO signaling could function to promote the growth of PCSCs and also the development of metastatic CRPC. Besides eNOS-NO as potential targets, targeting its upstream regulators (ERRα and ERG) of eNOS-NO signaling could also be the therapeutic strategy for the management of advanced prostate cancer, particularly the aggressive cancer carrying with the TMPRSS2:ERG fusion gene.